New concept for an investors web site.

In order to join, one has to be pre-qualified by taking and passing an investment exam. Not nearly as hard as the Series 7, Principals or FINOP but something that would be at least representative of say having the intelligence of a 3rd grader.

At the risk of one more time -

Wasting my time again in BB Fantasyland.
Searching for one who's got some real facts.
Some people say, a women's to blame.
But in this case, it's his own d fault.

1. GE has a special division that does nothing other than look for small acquisitions. Of course that assumes one thinks that VODG's platform patented or patent pending products would be small. If interested I can get you a copy of their acquisition model.

2. Personally involved with several small companies, from BB to private that were sold to multi-billion, international companies.

3. What about prior VODG board members from the likes of Scherer and Lilly?

I don't care what you think about VODG or for that matter any other stock. I just care that maybe, just maybe learn to use your head before you try to put your nose where it shouldn't be.

Good news! VODG is working on a cure via their patented and patent pending cell immortaliztion platforms for alzheimers.

Reason to believe press release seals it.
Am pleased to see the release today as we have been anticipating it.

"In addition, the terms of the agreement underlying this funding include expansion of the Board of Directors". (Emphasis added)

Given the background, experience, etc. of the equity investors, this confirmation of what we have been anticipating significantly increases the likelihood of success for VODG shareholders.

Very nice week, technically using Candlesticks.
1). This week's move engulfed the prior week which was the fourth down week. Strong.
2). Prior engulfing pattern was 02/25/08 which marked the low of this year and saw a move from $0.08 to $0.30.
3). February's low was a higher low than the lows from 07-10 of 2007.
4). Only technical negative I can see is the 03 high failed to best the 11/12/07 high.
5). $0.30 has been an important trading level for years, maybe this time the stock can move through it and hold on to it's gains.
6). Ain't this grand? Actually, if it works, it will be more than a grand or two or three or ...

One of my early teachers drilled into my head that emotion and investing don't mix. Maybe that's because of my gender, but, IMO he was right.

The life cycle of VODG is still very young, but extremely healthy and entering into the stage of rapid development. (Now that sure is a blinding glimpse of the obvious.)

In these days it is magnificent to have an investment who's success doesn't have much of anything to do with the price of oil, gold or the state of the economy.

With maybe one very important exception.

How many barrels of oil or ounces of gold would you spend to cure your diabetes?

A news update.

What Do Harry Houdini and MITD Have in Common?

Management has had nothing to say recently because they appear to have a corporate policy of only releasing good news.

Well, here is some information dug up from contacts living in Savannah, GA. where the Company is headquartered.

From the recent 10K, Page 1:

"ITEM 1. DESCRIPTION OF BUSINESS
Overview

MIT Holding, Inc., a Delaware corporation, is a holding company. Through three wholly-owned subsidiaries MIT distributes wholesale pharmaceuticals, administers intravenous infusions, operates an ambulatory center where therapies are administered and sells and rents home medical equipment.

We are located at 37 West Fairmont Avenue, Suite 202, Savannah, Georgia, 31406. The phone number is (912) 925-1905. The website is www.mitholdinginc.com. Shares of MIT Holding common stock are traded on the OTC Bulletin Board under the symbol MITD.OB. Our principal executive offices are located at 37 West Fairmont Ave., Suite 202, Savannah, GA 31406."

AND Page 2:

"Strategy

MIT’s strategy is to focus primarily on the domestic and international wholesale distribution of IVIG and other plasma based pharmaceuticals...

In addition, MIT will seek to increase its domestic wholesale distribution business by focusing its sales and marketing efforts on hospitals and other institutional purchasers. To date, MIT has generated minimal revenues from international sales."

Facts:
(A) Howard Schindell, possibly the smartest in the group, convicted of criminal fraud, has left the country.

That nearly $3 million in international sales booked last year has yet to materialize!

Nice job, Howard.

(B) MITD stated it looks for growth to be driven by Wholesale Drug sales.

How can a Company sell products via it's Wholesale Pharmaceutical subsidiary when 4 out of 5 sales people have left the Company????????

Answer - Unless you are Harry Houdini, don't think it can be done.

(C) Infusion Subsidiary - All locations except the Savannah infusion center have been shut down. Kinda difficult to grow a business when you're forced to shut so many centers down.

Unless of course, you are Harry Houdini.

(D) Then there is the little thing about a sexual abuse suit that has been unreported by management but can be found at the Chatham County Court web site. 3 suits looking for $1 million each plus punitive.

Guess if you were Harry Houdini, this wouldn't bother you either.

(E) Then there is the small thing of the Company's web site referred to in the above quote. Let me know if you can find it!

So what do MITD and Harry Houdini have in common?

My answer is - They both are dead, only MITD isn't public knowledge.

Had to chuckle about your "safe" comment. As an old movie enthusiast, Dustin Hoffman came to mind. If I remember correctly, Marathon Man and a Dr. doing some dental work. As he drilled Dustin Hoffman he would ask- "Is it safe?".

Totally agree with you that VODG is safe from the diseases that infect many BB investments. (Check out the MITD scam sometime.) Furthermore, Dr. Musick has done an exceptional job in protecting shareholder value and moving this company to possibly be the first to mass produce a product via cell immortalization that is cancer and rejection free!!!

Would welcome a further decline in the price of the stock with some nice volume. Why? With added financing my position can be increased and I know of other interested parties.

Did you email or speak with Dr. Musick as to VODG's participation?

The never ending story.

Some recent events have brought back to mind my post on the history of VODG and trading volume.

One could have summed up my general read on long time shareholders with one term - skeptical.

Based on the calls from long term shareholders that have contacted me due to recent events provides a possibly interesting insight into the upcoming marketplace.

Several skeptics are interested in getting current and after my conversations I would bet some of these turn into buyers. Wider sponsorship from investors who understand the time frame, etc. would be sweet.

You absolutely don't need to be concerned as to your questions on the fertility drug.

The following is my own opinions based on substantial DD to find out an answer to the same question you had, David.

Yes, Dr. Musick was involved in the sale of the antigen division, but he didn't make the decisions or pull the trigger. The individual who made them sold the division at a fraction of what it should have been sold to Roger Hurst who then set up Aspen Bio and went public. The guy who sold it ended up with a major interest in Roger's company (didn't have two pennies to rub together so it wasn't his personal funds). I deeply believe the stock from Roger was in payment for his dirty deeds. David, if you recall I asked you one time if you had ever run into anything about this. I have often wondered how Dr. Musick could have worked with a used car salesman like Roger Hurst.

I also uncovered, during this same time frame, that a Denver IB had an interested buyer for the fertility business and was willing to pay between $1-2 per share. Of course these events were many years ago.

Dr. Musick may - and has - made some poor business decisions, who hasn't? But I have never found him to be unethical in any manner or form.

Finally, in closing;

VODG - An honest, shareholder oriented investment in the Fantasy Land of Bulletin Board Stocks! IMO, epitomizes what long term BB investors should be looking for and we are lucky enough to be shareholders. Whatever happens, the way I look at things, investing doesn't get any better than this!

Third consideration from funding.

"Management believes that the advanced state of its technology and long-term commitment to cell line generation places Vitro at a significant competitive advantage in the global efforts to commercialize pancreatic stem cell technology."

And get this -
"We have a unique opportunity to leverage our advanced stem cell differentiation technology into becoming the first firm to market stem cell-derived human pancreatic beta islets."

Further opportunities from funding:

"Our new facility is now in advanced stages of construction and, when complete, will accommodate our corporate headquarters, manufacturing and R&D. This modern laboratory will expand our operational capacity and also allow for additional future expansion. We now have the financial support to expand our resources in an effort to achieve our business goals, including commercialization of products derived from our stem cell technology targeting markets in diabetes research, drug development and animal therapeutics.

Notice not only human application buy animal.

Something additional funding should help to accomplish.

The following is taken from the recent Letter to Shareholders:

"We are now focused on the development of products and technologies for potential use in the treatment of diabetes both through the development of new tools for use in drug discovery and development as well as for cell transplantation of stem cells or their products to eventually lead to more advanced treatments for diabetes. In addition, our technology may have broader application by allowing generation of other cell lines of medical value such as heart cells, muscle cells and blood cells."

My years of research would support this conclusion.

To my knowledge the Company hasn't given a specific time table. With your molecular biology background, I would assume you have some decent if not very good knowledge of the patent process.

Based upon articles and other public disclosures one can at least get into the ball park with a pretty good idea. I am referring to the 2007 10K, recent letter to shareholders and the WST article from last year.

I would suspect shortly and most likely before the finalization of the current funding.

It really is amazing and brings back the concept of the possibility that VODG could be the FORD of the 21st century.

Here is what else is amazing.

Most, if not all of you are seasoned (to some degree) BB investors/traders. Let me put it into a question:

Isn't VODG the epitome of what BB land is all about
AND
what most investors/traders are constantly trying to find?

Very nicely done! Like to see the new guys get deeper into it as well. Improves the confidence that even if the business plan doesn't work, these guys could make it work.
One terrific investment for BB land!

From this past episode, I would be interested in knowing what people think regarding:

1). What 3 things did you learn about Dr. M?
2). In what ways is VODG like other BB stocks?
3). In what ways does VODG differ from other BB stocks?

My banks on the other wire.
to be sung to Jerry Lee's Great Balls of Fire.

My Bankers on D Wire.
You shake my nerves and you rattle my brain.
No PR causes me great pain.
You broke my bank, fraid the stocks gonna tank,
Goodness gracious, my bankers on d wire!

International Sales

2005 $11.5 million

2006 $8.8 million

2007 $3.8 million (actual)

cheer up things can't get much worse!

MITD you read and decide. No gripe, no slander, just the facts.

The following is something Ben Glison & Kenneth Lay would be mighty proud of.

From the 2007 10K filed 4/15/2007.

Page 25 of the SEC Filing:
"... the Company has a single receivable from a customer in the Dominican Republic for $2,416,500. Terms of the invoice are 25%-60/25%-90/25%-180/25%-360. The initial installment was due September 20, 2007. This receivable is included in our revenues for 2007, Nine thousand dollars has been received on this invoice. The Company is relying upon collection of the balance of this invoice to expand its international sales. As of December 31, 2007, this receivable remained uncollected.

This receivable, according to the 3Q Filing was invoiced on June 20, 2007. And according to that filing the $2.4 million in sales generated $1.5 million in Net Income!!!

In other words the reported $12.7 million in revenues was really more like $10.3 million and the net income of $79,890 includes the stated net income from the 3Q filing, page F-13 of $1,518,199. Resulting in a loss of $1.4 million.

Sounds like strike one and strike two.

Now look at this, also on Page 25 of the 2007 10K Filing.

"On April 4, 2008, we received a letter from Northern indicating that Northern considered MIT in default of its obligations under the credit agreement, and declaring all amounts under the credit agreement due and payable in full immediately. Subsequent to this letter, we received oral assurances from Northern that they would continue to fund MIT for an additional 60 days from April 4. We can make no assurances that Northern will continue to fund MIT for that period, no assurances we will be able to pay Northern at the end of that period, and no assurances that we will be able to find alternate funding on terms favorable to the Company or at all."

Strike three. In the red and hanging by a thread.

Caveat Empty.

Rocky Parker, but the scamming extends down the line.
You thought MITD reported $12 million in revenues and a net profit. You thought their business plan was to grow international sales.

The following is just a sample of creativity that Ben Glisan and Kenneth Lay would wink at!

From the 2007 10K filed 4/15/2007.

Page 25 of the SEC Filing:
"... the Company has a single receivable from a customer in the Dominican Republic for $2,416,500. Terms of the invoice are 25%-60/25%-90/25%-180/25%-360. The initial installment was due September 20, 2007. This receivable is included in our revenues for 2007, Nine thousand dollars has been received on this invoice. The Company is relying upon collection of the balance of this invoice to expand its international sales. As of December 31, 2007, this receivable remained uncollected.

This receivable, according to the 3Q Filing was invoiced on June 20, 2007. And according to that filing the $2.4 million in sales generated $1.5 million in Net Income!!!

In other words the reported $12.7 million in revenues was really more like $10.3 million and the net income of $79,890 includes the stated net income from the 3Q filing, page F-13 of $1,518,199. Resulting in a loss of $1.4 million.

Sounds like strike one and strike two.

Now look at this, also on Page 25 of the 2007 10K Filing.

"On April 4, 2008, we received a letter from Northern indicating that Northern considered MIT in default of its obligations under the credit agreement, and declaring all amounts under the credit agreement due and payable in full immediately. Subsequent to this letter, we received oral assurances from Northern that they would continue to fund MIT for an additional 60 days from April 4. We can make no assurances that Northern will continue to fund MIT for that period, no assurances we will be able to pay Northern at the end of that period, and no assurances that we will be able to find alternate funding on terms favorable to the Company or at all."

Strike three. In the red and hanging by a thread.

Caveat Empty.

MITD - something Ben Glison & Kenneth Lay would be mighty proud of.

From the 2007 10K filed 4/15/2007.

Page 25 of the SEC Filing:
"... the Company has a single receivable from a customer in the Dominican Republic for $2,416,500. Terms of the invoice are 25%-60/25%-90/25%-180/25%-360. The initial installment was due September 20, 2007. This receivable is included in our revenues for 2007, Nine thousand dollars has been received on this invoice. The Company is relying upon collection of the balance of this invoice to expand its international sales. As of December 31, 2007, this receivable remained uncollected.

This receivable, according to the 3Q Filing was invoiced on June 20, 2007. And according to that filing the $2.4 million in sales generated $1.5 million in Net Income!!!

In other words the reported $12.7 million in revenues was really more like $10.3 million and the net income of $79,890 includes the stated net income from the 3Q filing, page F-13 of $1,518,199. Resulting in a loss of $1.4 million.

Sounds like strike one and strike two.

Now look at this, also on Page 25 of the 2007 10K Filing.

"On April 4, 2008, we received a letter from Northern indicating that Northern considered MIT in default of its obligations under the credit agreement, and declaring all amounts under the credit agreement due and payable in full immediately. Subsequent to this letter, we received oral assurances from Northern that they would continue to fund MIT for an additional 60 days from April 4. We can make no assurances that Northern will continue to fund MIT for that period, no assurances we will be able to pay Northern at the end of that period, and no assurances that we will be able to find alternate funding on terms favorable to the Company or at all."

Strike three. In the red and hanging by a thread.

Caveat Empty.

2007 10K Nice Read.

Check this out page 25 of the SEC Filing:
"... the Company has a single receivable from a customer in the Dominican Republic for $2,416,500. Terms of the invoice are 25%-60/25%-90/25%-180/25%-360. The initial installment was due September 20, 2007. This receivable is included in our revenues for 2007, Nine thousand dollars has been received on this invoice. The Company is relying upon collection of the balance of this invoice to expand its international sales. As of December 31, 2007, this receivable remained uncollected.

This receivable, according to the 3Q Filing was invoiced on June 20, 2007. And according to that filing the $2.4 million in sales generated $1.5 million in Net Income!!!

In other words the reported $12.7 million in revenues was really more like $10.3 million and the net income of $79,890 includes the stated net income from the 3Q filing, page F-13 of $1,518,199. Resulting in a loss of $1.4 million.

Sounds like strike one and strike two.

Now look at this, also on Page 25 of the 2007 10K Filing.

"On April 4, 2008, we received a letter from Northern indicating that Northern considered MIT in default of its obligations under the credit agreement, and declaring all amounts under the credit agreement due and payable in full immediately. Subsequent to this letter, we received oral assurances from Northern that they would continue to fund MIT for an additional 60 days from April 4. We can make no assurances that Northern will continue to fund MIT for that period, no assurances we will be able to pay Northern at the end of that period, and no assurances that we will be able to find alternate funding on terms favorable to the Company or at all."

Strike three. In the red and hanging by a thread.

Caveat Empty.

Sage of the Sierra, you nailed it again!

And frankly, I think it is a class way of doing things. (Obviously, I am thinking the deadline was met.)

Take care of business, after all there aren't a lot of extra people floating around to do press releases, etc. Once the i's are dotted, t's crossed, money in the bank, then a press release. After all, management isn't here to hype the stock, just deliver on business. Sweet.

A multiple choice question:

What is the most important thing to management and the company regarding today's deadline?
A). Informing a bunch of wired investors if the deadline was met.
B). Putting out a massive, coordinated PR in an effort to pump your stock.
C). Making real sure the deadline is met so the additional capital infusion occurs, press release can follow.
D). Scheduling interviews on all the morning talk shows.

He may have simply mis-spoke by using the term divest, or ...
I would think it would be worth more today because other patents and lab experience have proven very positive in other areas that use similar science.

Something caught my attention upon re-reading the shareholder's letter. I will attempt to clarify this with management.

Here is what I was referring to:
"Vitro owns patented technology for the production of fertility drugs and we may DIVEST these assets to focus on stem cell related products."

Odd to say divest, unless one has been working on selling a portion of the business and decided (been advised by lawyers and tax specialists) the advantages of "divesting".

It suggests forethought of action. In futures past, I was aware of an interested party for the FSH business represented by a Denver IB. If memory serves me, willing to pay $1-2 per share. Again, this was futures past and probably not all that relevant today.

A take on today's low volume.

IMO, the low volume in front of pending outstanding news can be interpreted from the experiences of the past 10 years. VODG is a great example of a "show-me" stock. The past has proven there is no reason to believe in the future.

This attitude is the one needed to precisely establish the opportunity that exists today. Without it, it simply wouldn't exist of possibly happen.

High volume in anticipation of the news, by its nature, would have brought into serious question this story. In fact, had there been higher volume, I would likely have considered the old trading axiom "buy the rumor sell the fact".

I think the low volume is a continuation of the story and one that reinforces it. It tells of a good possibility of a very bright future.

Volume and VODG.
One person's look at the long-term charts of VODG.
The ten year monthly chart shows 4 times of high volume:

Volume to the North.
1). 1999 - 2000
Over this time period the stock moved from $0.30-4.75 representing the largest and longest upward move in the stock. It was associated with the specter of change. Major shareholder was bought out, etc. Nice "tradeable" move.
2). 11/04 - 4/05
Nice volume, but the stock only moves from $0.11-0.49. Tough, but "tradeable", believe the catalyst was an article or two on the Company.
3). 5/06
500,000 shares take the stock from $0.02 to a high of $0.058. This, I think you will find, was do to an article in the Wall Street Transcript. The next year, I speculated in a possible follow-up on the prior year WST article based on experience of their method of operation. Lower volume, ho-hum, who cares response. Was able to buy a nice dinner with my trading profits.

My long term story on this is continued decline in expectations which set up the final high volume move:

SOUTH!
1). Would argue a long term selling climax. Highest volume in 10 years AND the LOWEST PRICE!!! As I have stated, I was just dumb arsh lucky to be there.

Long Term Conclusion.
IMO, one beautiful long term technical reason to be long VODG, not as a trader but as a long term investor, with hope that fundamentals would follow.

One man's chicken is another man's dinner. Then again, there is the possibility that he or she knows something we don't.

Not bashing, simply recognizing these little puppies in BB land are just that, puppies. IMO, VDOG has an outstanding chance of becoming a greyhound.

There are numerous examples of folks getting scorched by BB stocks. Maybe I am too close to VODG, but...
It certainly seems like this has got to be one of the best risk/reward investments in many years. Help me, from any angle I can't find a good argument as to why someone buying VODG stock doesn't have an outstanding risk/reward relationship.

Could the worst thing to happen be Dr. M. no longer in the scene? Given what has happened on the R&D side over the years, if Dr. M. weren't on the scene, it certainly appears the probabilities very good that the Company could be (would be?) put into play.

Only negatives I can come up with are:
1). lost opportunity, due to various situations;
2). manufacturing doesn't materialize at all.

What's the risk - back to $0.10, or $0.05 and the probabilities of said risk?
NOW.
What's the reward? Ahhhhh... decent, substantial, enormous.
Seems like given the reward, lost opportunity isn't a very good argument.

So tell me, doesn't VODG offer one of the best risk/reward relationships you have seen in years? Where am I wrong?

A few years ago I would have argued if the Dr. was removed from the equation there would be significant risk to other shareholders.

As far as I know he is in good health. Several years ago he had prostrate cancer with no recurrences. To my knowledge there is no key-man insurance.

This is not a subject I would bring up with him, but what ever you want to do is obviously up to you.

Today, I would argue that the only risk to shareholders is a short term one if Jim became ill or couldn't see his life long dream to reality. Enough science has been developed, patented, etc. to preserve the value of the life that has been poured into it. The stock would likely end up in his wife's control.

My suggestion would be if you want to pursue a discussion with the good Dr. to find out that in the event of his being incompetent, etc. who would control his stock and have majority ownership.

Finally, one could argue that Dr. Musick's presences doesn't matter for the long term success of the Company at this point in time. Short term could be another story, but maybe not.

No and your comment is just another example of why I hesitate to post on these boards.

1). If you haven't, which your post would indicate that you haven't, take a few minutes and review my posts and some of the other excellent DD, especially all the time Davidam has put into this company.
2). Even so, I have the right to have an opinion that the stock would go lower if the deadline were not met. Anybody with an IQ above 50 could figure that out.
3). So why don't we get a few learning impaired individuals to cook us up some real stew?

Davidam, your post needs some clarification. You have had some discussions with Dr. Musick about the potential and benefits derived from a Wall Street Journal Transcript article similar to the ones he has had over the years. At this point in time there is absolutely no way to know if the article will appear at all.

Everything else you state is right on!

IMO, Dr. Musick is way to intelligent to publicly state a date that he didn't have in his hip pocket. In addition, he walks the walk, meaning in over 10 years of following VODG, I have confidence in his integrity. Finally, I would probably be personally happier if some glitch came up that caused the date to be missed by a week.

Ya, some days are like that with VODG. Take a look at the LT charts and you will see many days like today. News does drive the stock, both price and volume. The trick is getting positioned before and having the right position. Ah, minor points, but in this situation we know that news is coming within a few weeks.

A possible good thing about sideways action here for a while would give the stock a "breather" and let RSI, etc. settle back in possibly providing more to the upside. Small assumption that the next meaningful move is north.

Another thing I did in the past but found it to be too time consuming - mailing list of Master Pumpsters.
What I have found helpful and profitable about spikes in posting activity:

1). When it first occurs I admit I have made some short term (1 to 3 or so day duration) trades. Decent profits, complete speculation - understand and can live with. Know nothing about fundamentals or even what the company does or doesn't do. Completely instinctual trading for me and I don't look back.

2). Check board activity before I really get into the research. What I see dictates what I do. Can amplify if you wish.

3). You are absolutely correct on the typical BB shareholder. At times I find it difficult to spend time on the boards because it is so unproductive. In addition, and I don't mean this to sound like the typical testosterone driven BB participant in the least, but frankly I know my companies as well if not better than anybody limited to public information. So I often ask myself, why bother?

Thanks for getting back to me.

Would suggest there could be three similarities of BB scams. This comes from personal experience, etc.
1). Blind greed.
2). Great arrogance.
3). A little too, well, righteous acting.

Many scams can be uncovered by good financial analysis.

I would like to refine your well taken point. Investing in the fantasy land of Bulletin Board stocks one must recognize that by their nature, fantasies come in all shapes and sizes.

As one does their DD, to think that their potential investment is scam free because of size - big or small - is asking to get scammed.